Skip to main content
Clinical Trials/NCT07100431
NCT07100431CompletedNot Applicable

Comparison of Safety and Clinical Effects of Straight and Articulated Instruments (ArtiSential) in Laparoscopic Gastrectomy for Gastric Cancer Patients, a Prospective Randomized Study

Gangnam Severance Hospital1 site in 1 country76 target enrollmentStarted: June 22, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
76
Locations
1
Primary Endpoint
The reduction in operative time achieved by using an articulating instrument for dissection of suprapancreatic lymph nodes during laparoscopic gastrectomy

Study Overview

Brief Summary

In patients with gastric cancer, gastrectomy can be performed via laparoscopic/robotic or open surgery. It is crucial to completely remove the tumor along with an adequate extent of lymph node dissection. The number of lymph nodes retrieved during gastrectomy is considered an important factor associated with the quality of the surgery and can serve as an indicator of the completeness of the procedure.

In particular, during the dissection of lymph node stations 8, 9, 11p and 12a - which are located near the superior aspect of the pancreas - pressure is often applied to the pancreas to secure an adequate surgical view. Recent studies have suggested that this may be associated with postoperative pancreatic complications.

It is believed that the use of articulating instruments during laparoscopic gastrectomy may enable a safer dissection of lymph nodes located above the pancreas. However, to date, there have been lack of studies comparing the safety and efficacy of articulating versus straight instruments in laparoscopic gastrectomy. Therefore, this study aims to analyze the compare these two approaches.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Masking Description

Patients were randomly assigned in a 1:1 ratio to two groups; the control group or the experimental (Articulating) group.

Eligibility Criteria

Ages
20 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients diagnosed with gastric adenocarcinoma pathologically before surgery
  • •Patients scheduled for laparoscopic radical gastrectomy
  • •Patients aged more than 20
  • •Patients with an ECOG 0 or 1

Exclusion Criteria

  • •Patients with a history of gastrectomy
  • •Patients with a history of pancreatitis or pancreatic surgery
  • •Patients with a history of abdominal surgery who are expected to have severe intra-abdominal adhesions
  • •Patients scheduled for total gastrectomy with D2 lymph node dissection

Arms & Interventions

Articulating group

Experimental

During supra-pancreatic lymph node dissection, the assistant provides downward traction on the pancreas head with an articulating laparoscopic instrument (ArtiSential®, LIVSMED, Maryland jaw) in their left hand.

Intervention: Articulating (experimental group) (Procedure)

Articulating group

Experimental

During supra-pancreatic lymph node dissection, the assistant provides downward traction on the pancreas head with an articulating laparoscopic instrument (ArtiSential®, LIVSMED, Maryland jaw) in their left hand.

Intervention: Control (control group) (Procedure)

Control group

No Intervention

During supra-pancreatic lymph node dissection, the assistant provides downward traction on the pancreas head with a conventional straight laparoscopic instrument in their left hand.

Outcomes

Primary Outcomes

The reduction in operative time achieved by using an articulating instrument for dissection of suprapancreatic lymph nodes during laparoscopic gastrectomy

Time Frame: During surgery, the total operation time, and the supra-pancreatic lymph node dissection time will be calculated respectively. The supra-pancreatic lymph node dissection time will be measured from the point of right gastric artery ligation to just before

To confirm that the use of articulating instruments in radical gastrectomy can lead to more efficient and safer surgery compared to conventional straight instruments.

Secondary Outcomes

  • The number of retrieved lymph nodes(The number of retrieved lymph nodes were counted after surgery)
  • The degree of pancreas injury after surgery(Amylase levels will be measured in serum and peritoneal fluid on postoperative day 1 and 3.)
  • Estimated blood loss(Estimated blood loss will be calculated during surgery.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

In Gyu Kwon

Assistant Professor

Gangnam Severance Hospital

Study Sites (1)

Loading locations...

Similar Trials

Comparison of Safety and Clinical Effects... | Clinical Trial